Latest Headlines

  1. CDMO Wheeler Bio Announces Plans To Build Out Large-Scale Biologics Manufacturing Facility In Oklahoma 3/25/2025
  2. Upperton Pharma Solutions Wins Champion Award At 2025 CDMO Leadership Awards In Small Molecule Dosage Form Category 3/24/2025
  3. Johnson & Johnson Announces $55 Billion Manufacturing Investment In United States 3/21/2025

    Johnson & Johnson, healthcare’s leading, most comprehensive innovation powerhouse, announced manufacturing, research and development, and technology investments of more than $55 billion in the United States over the next four years.

  4. Upperton Continues Strategic Growth With The Appointment Of Michael Mellor-Clark As Chief Commercial Officer 3/20/2025

    Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), continues its growth following the build of a new sterile manufacturing facility with the appointment of Michael Mellor-Clark as Chief Commercial Officer (CCO).

  5. Entos Pharmaceuticals Announces Plans To Build $198M Facility In Alberta Canada 3/20/2025

    Entos® Pharmaceuticals (Entos), a clinical-stage genetic medicines company committed to using its Fusogenix™ PLV™ technology to develop cures, has announced a $62 million investment from the Government of Canada. This funding leverages a previously announced $15.5 million awarded to Entos from the Government of Alberta.

  6. CDMO Delpharm Announces Plans To Upgrade Sterile Manufacturing Facility In Quebec 3/19/2025

    Delpharm, a world leader in pharmaceutical outsourcing, announced that it has reached an agreement with the Government of Canada to modernize its injectable manufacturing facility in Boucherville.

  7. Aseptic Filling System Provider Announces New Chief Commercial Officer 3/17/2025

    AST, a leading provider of flexible aseptic filling systems, is pleased to announce an exciting addition to the Leadership team. Charisse Curtis has joined AST as Chief Commercial Officer, leading the Business Development, Marketing, and Communications teams. 

  8. Körber And HighByte Partner To Accelerate The Digital Transformation Of Manufacturing In Life Sciences 3/17/2025

    Körber has officially certified HighByte Intelligence Hub for seamless integration with PAS-X MES as part of the Körber Ecosytem Partner Program. HighByte has achieved the “PAS-X MSI Plug & Produce” certification. This partnership empowers life sciences manufacturers to fast-track their digital transformation, enabling improved data visibility, enhanced operational agility, and increased manufacturing efficiency.

  9. Halo Pharma's Whippany NJ Facility To Offer Sterile Injectable Manufacturing Services With $25 Million Investment 3/17/2025

    he Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million investment in its Halo Pharma facility in Whippany, New Jersey, to establish sterile injectable manufacturing capabilities, including ready-to-use, syringe, cartridge, and vial filling.

  10. Curia Announces Expansions To Global Network Of Sterile Fill-Finish Sites 3/17/2025